Advertisements
Feeds:
Posts
Comments

Search Results for 'Acute Coronary Syndrome'

Acute Coronary Syndrome (ACS): Strategies in Anticoagulant Selection: Diagnostics Approaches – Genetic Testing Aids vs. Biomarkers (Troponin types and BNP)

Posted in Acute coronary syndrome, Acute Myocardial Infarction, Frontiers in Cardiology and Cardiovascular Disorders, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genomic Testing: Methodology for Diagnosis, Genomics Pharmacy, Myocardial metabolism, Myocardial ischemia, Myocardial adenine nucleotide metabolism, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease on March 13, 2018| Leave a Comment »


Acute Coronary Syndrome (ACS): Strategies in Anticoagulant Selection: Diagnostics Approaches – Genetic Testing Aids vs. Biomarkers (Troponin types and BNP) Curator: Aviva Lev-Ari, PhD, RN   UPDATED on 3/17/2018 An NT-proBNP <300 pg/ml strongly excludes the presence of acute HF. J Am Coll Cardiol. 2018 Mar 20;71(11):1191-1200. doi: 10.1016/j.jacc.2018.01.021. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED […]

Read Full Post »

ODYSSEY Outcomes trial evaluating the effects of a PCSK9 inhibitor, alirocumab, on major cardiovascular events in patients with an acute coronary syndrome to be presented at the American College of Cardiology meeting on March 10.

Posted in Atherogenic Processes & Pathology, Frontiers in Cardiology and Cardiovascular Disorders, Heart Failure (HF), inflammation independent of lipid levels, Lipid metabolism, Lipidomics, Lipids, Origins of Cardiovascular Disease, PCSK9 Inhibitor Therapy, Pharmacotherapy of Cardiovascular Disease, tagged on February 28, 2018| Leave a Comment »


ODYSSEY Outcomes trial evaluating the effects of a PCSK9 inhibitor, alirocumab, on major cardiovascular events in patients with an acute coronary syndrome to be presented at the American College of Cardiology meeting on March 10. Reporter: Aviva Lev-Ari, PhD, RN   For PCSK9 inhibitors, the effect on major adverse cardiovascular events has always fallen short of expectations based on […]

Read Full Post »

In Europe, BigData@Heart aim to improve patient outcomes and reduce societal burden of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS).

Posted in Frontiers in Cardiology and Cardiovascular Disorders, tagged on July 10, 2017| Leave a Comment »


In Europe, BigData@Heart aim to improve patient outcomes and reduce societal burden of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS). Reporter: Aviva Lev-Ari, PhD, RN   PRESS RELEASE The objective of BigData@Heart is to develop a data-driven translational research platform of unparalleled scale and phenotypical resolution, with the aim to improve […]

Read Full Post »

Recent Insights into the High Sensitivity Troponins for Acute Coronary Syndromes

Posted in Frontiers in Cardiology and Cardiovascular Disorders on September 8, 2014| Leave a Comment »


Recent Insights into the High Sensitivity Troponins for Acute Coronary Syndromes   Curator: Larry H Bernstein, MD, FCAP   This piece is a conclusion of the series on myocardial markers, which has become a Gold Standard over the last 15 years, beginning with the introduction of the standard assays, and then migrating to the high […]

Read Full Post »

Titanium-nitric-oxide-coated bioactive stents in acute coronary syndrome

Posted in Uncategorized on August 10, 2014| Leave a Comment »


Originally posted on Leaders in Pharmaceutical Business Intelligence (LPBI) Group:
Titanium-nitric-oxide-coated bioactive stents in acute coronary syndrome Reporter: Larry Bernstein, MD, FCAP SOURCE: http://www.researchgate.net/publication/256607204_Stent-oriented_versus_patient-oriented_outcome_in_patients_undergoing_early_percutaneous_coronary_intervention_for_acute_coronary_syndrome_2-year_report_from_the_BASE-ACS_trial REBLOG Titanium-nitric-oxide-coated bioactive stents in acute coronary syndrome: towards a more clear landscape! Wail N. Assisstant Professor of Cardiology, Faculty of Medicine, Ain Shams University, Egypt With full interest, we read the…

Read Full Post »

Titanium-nitric-oxide-coated bioactive stents in acute coronary syndrome

Posted in Cardiac and Cardiovascular Surgical Procedures, Frontiers in Cardiology and Cardiovascular Disorders, Stents & Tools, tagged , on August 10, 2014| 2 Comments »


Titanium-nitric-oxide-coated bioactive stents in acute coronary syndrome Reporter: Larry Bernstein, MD, FCAP SOURCE: http://www.researchgate.net/publication/256607204_Stent-oriented_versus_patient-oriented_outcome_in_patients_undergoing_early_percutaneous_coronary_intervention_for_acute_coronary_syndrome_2-year_report_from_the_BASE-ACS_trial REBLOG Titanium-nitric-oxide-coated bioactive stents in acute coronary syndrome: towards a more clear landscape! Wail N. Assisstant Professor of Cardiology, Faculty of Medicine, Ain Shams University, Egypt With full interest, we read the Editorial “Nitric-oxide Coated Bioactive Titanium Stents: Safer and More Effective […]

Read Full Post »

Two-dimensional speckle tracking–derived strain to distinguish acute coronary syndrome from a marked early repolarization in a patient with chest pain: A fancy gadget or a useful tool

Posted in Uncategorized on November 8, 2013| Leave a Comment »


See on Scoop.it – Cardiovascular and vascular imaging Echocardiography See on http://www.mdlinx.com

Read Full Post »

G Protein–Coupled Receptor and S-Nitrosylation in Cardiac Ischemia and Acute Coronary Syndrome

Posted in Cardiovascular Research, Cell Biology, Signaling & Cell Circuits, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Frontiers in Cardiology and Cardiovascular Disorders, Metabolomics, Myocardial metabolism, Myocardial ischemia, Myocardial adenine nucleotide metabolism, Nitric Oxide in Health and Disease, Population Health Management, Genetics & Pharmaceutical, Pre-Clinical Animal Model Development, Proteomics, Technology Transfer: Biotech and Pharmaceutical, tagged , , , , , , , , , , , , , , on November 2, 2013| Leave a Comment »


G Protein–Coupled Receptor and S-Nitrosylation in Cardiac Ischemia Curators: Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN   This recently published article delineates a role of G-protein-coupled receptor with S-nitrosylation in outcomes for acute coronary syndrome. Convergence of G Protein–Coupled Receptor and S-Nitrosylation Signaling Determines the Outcome to Cardiac Ischemic Injury Z. Maggie Huang1, Erhe […]

Read Full Post »

Coronary Circulation Combined Assessment: Optical Coherence Tomography (OCT), Near-Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) – Detection of Lipid-Rich Plaque and Prevention of Acute Coronary Syndrome (ACS)

Posted in Atherogenic Processes & Pathology, Cardiac and Cardiovascular Surgical Procedures, Frontiers in Cardiology and Cardiovascular Disorders, Medical Devices R&D and Inventions, Medical Imaging Technology, Image Processing/Computing, MRI, CT, Nuclear Medicine, Ultra Sound, Origins of Cardiovascular Disease, PCI, Peripheral Arterial Disease & Peripheral Vascular Surgery, tagged , , , , , , , , , on August 25, 2013| 6 Comments »


Coronary Circulation Combined Assessment: Optical Coherence Tomography (OCT), Near-Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) – Detection of Lipid-Rich Plaque and Prevention of Acute Coronary Syndrome (ACS) Author, and Content Consultant to e-SERIES A: Cardiovascular Diseases: Justin Pearlman, MD, PhD, FACC and Article Curator: Aviva Lev-Ari, PhD, RN The clinical motivations for coronary artery imaging include identifying […]

Read Full Post »

Gender Differences and Acute Coronary Syndrome: The Clinical Implications – Pharmacy Times

Posted in Uncategorized on August 15, 2013| Leave a Comment »


See on Scoop.it – Cardiotoxicity Gender Differences and Acute Coronary Syndrome: The Clinical Implications Pharmacy Times Clinicians prescribe beta-blockers less frequently for women than for men, but women who are prescribed beta-blockers achieve higher plasma levels and exhibit… See on http://www.pharmacytimes.com

Read Full Post »

Next »